Anas Hamad
Impact in
- Geriatrics and Gerontology top 10%
- Pharmaceutical Practices and Patient Outcomes
- Emergency Medical Services top 10%
- Healthcare Operations and Scheduling Optimization
- Patient Safety and Medication Errors
Papers in ⓘ
- Hematology 17
- Multiple Myeloma Research and Treatments 7
- Oncology 15
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Mohamed A. Yassin (12 shared papers)Adel Elomri (6 shared papers)Laoucine Kerbache (6 shared papers)Dina Abushanab (7 shared papers)Cate Whittlesea (2 shared papers)Paul Wade (2 shared papers)Gillian Cavell (2 shared papers)Abdelfatteh El Omri (4 shared papers)
- Journals
- Blood (7 papers)Frontiers in Oncology (4 papers)International Journal of Environmental Research and Public Health (3 papers)Frontiers in Immunology (2 papers)International Journal of Clinical Pharmacy (2 papers)
- Partner nations
- QatarUnited Arab EmiratesJordan
In The Last Decade
Anas Hamad
46 papers receiving 259 citations
Peers
Comparison fields: 5 of 75
- Geriatrics and Gerontology 50
- Emergency Medical Services 50
- Applied Microbiology and Biotechnology 13
- Hematology 40
- Genetics 31
Countries citing papers authored by Anas Hamad
This map shows the geographic impact of Anas Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Hamad more than expected).
Fields of papers citing papers by Anas Hamad
This network shows the impact of papers produced by Anas Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Hamad. The network helps show where Anas Hamad may publish in the future.
Co-authors
The 25 scholars most cited alongside Anas Hamad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 25 | |
| 2 | 2019 | 17 | |
| 3 | 2022 | 16 | |
| 4 | 2015 | 12 | |
| 5 | 2019 | 12 | |
| 6 | 2018 | 12 | |
| 7 | 2021 | 12 | |
| 8 | 2022 | 10 | |
| 9 | 2013 | 10 | |
| 10 | 2022 | 10 | |
| 11 | 2021 | 10 | |
| 12 | 2023 | 9 | |
| 13 | 2018 | 9 | |
| 14 | 2023 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2021 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2021 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2022 | 5 |
About Anas Hamad
Anas Hamad is a scholar working on Hematology, Oncology, Genetics, Geriatrics and Gerontology and Emergency Medical Services, having authored 56 papers that have together received 263 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (11 papers), Chronic Lymphocytic Leukemia Research (9 papers), Multiple Myeloma Research and Treatments (7 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Healthcare Operations and Scheduling Optimization (5 papers), Pharmaceutical studies and practices (4 papers) and Patient Safety and Medication Errors (4 papers). The work is most often cited by research in Geriatrics and Gerontology (50 citations), Emergency Medical Services (50 citations), Applied Microbiology and Biotechnology (13 citations), Hematology (40 citations) and Genetics (31 citations). Anas Hamad has collaborated with scholars based in Qatar, United Arab Emirates and Jordan. Frequent co-authors include Mohamed A. Yassin, Adel Elomri, Laoucine Kerbache, Dina Abushanab, Cate Whittlesea, Paul Wade, Gillian Cavell, Abdelfatteh El Omri, Mohamed Izham Mohamed Ibrahim and Abdulqadir J. Nashwan. Their work appears in journals such as Blood, Frontiers in Oncology, International Journal of Environmental Research and Public Health, Frontiers in Immunology and International Journal of Clinical Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.